Appili Therapeutics (PK)【APLIF】銘柄情報

Appili Therapeutics Inc (PK) (APLIF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.01186

( - )

買値

0.01186

売値

0.01186

出来高

0.00 日の範囲 0.00

0.0089 52 週間の範囲 0.0309

時価総額

1.57M

前日終値

0.01186

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 83,700

発行済株式数

132,366,120

配当利回り

PER

-0.85

1 株当たり利益 (EPS)

-0.02

歳入

206.31k

純利益

-2.96M

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anae... Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a liquid oral taste-masked reformulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701, a live-attenuated vaccine for the treatment of francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

appilitherapeutics.com

本社

Halifax, Canada

設立

2026

Appili Therapeutics Inc (PK) is listed in the Healthcare sector of the その他OTC with ticker APLIF. The last closing price for Appili Therapeutics (PK) was US$0.01. Over the last year, Appili Therapeutics (PK) shares have traded in a share price range of US$ 0.0089 to US$ 0.0309.

Appili Therapeutics (PK) currently has 132,366,120 shares in issue. The market capitalisation of Appili Therapeutics (PK) is US$1.57 million. Appili Therapeutics (PK) has a price to earnings ratio (PE ratio) of -0.85.

Appili Therapeutics to Exhibit at World Vaccine Congress Washington

Appili Presentation Highlights Recent Collaborations and Funding Milestones Appili Executives to Conduct...

Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia...

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

US$82 Million in Pending Proposals Across Multiple Infectious Disease Programs US$40 Million NIAID Funding...

Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia...

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026

New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across...

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia, Nov...

Appili Therapeutics to Attend BARDA Innovation Symposium 2025

HALIFAX, Nova Scotia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTC Pink: APLIF...

Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01

Awarded contract base period of US$3.6 million to fund vaccine manufacturing with additional option periods to...

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF...

Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference

HALIFAX, Nova Scotia, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	-0.00214	-15.2857142857	0.014	0.0182	0.0106	33609	0.0158003	CS
12	-0.00094	-7.34375	0.0128	0.0182	0.0105	60003	0.01334121	CS
26	-0.00294	-19.8648648649	0.0148	0.0189	0.0105	40498	0.01387918	CS
52	-0.00024	-1.98347107438	0.0121	0.0309	0.0089	40243	0.01514431	CS
156	-0.01114	-48.4347826087	0.023	0.0755	0.0089	139701	0.03140257	CS
260	-0.67712	-98.2786147639	0.68898	0.91	0.0089	103577	0.08704976	CS

APLIF - Frequently Asked Questions (FAQ)

What is the current Appili Therapeutics Inc (PK) share price?

The current share price of Appili Therapeutics Inc (PK) is US$ 0.01186

How many Appili Therapeutics Inc (PK) shares are in issue?

Appili Therapeutics Inc (PK) has 132,366,120 shares in issue

What is the market cap of Appili Therapeutics Inc (PK)?

The market capitalisation of Appili Therapeutics Inc (PK) is USD 1.57M

What is the 1 year trading range for Appili Therapeutics Inc (PK) share price?

Appili Therapeutics Inc (PK) has traded in the range of US$ 0.0089 to US$ 0.0309 during the past year

What is the PE ratio of Appili Therapeutics Inc (PK)?

The price to earnings ratio of Appili Therapeutics Inc (PK) is -0.85

What is the cash to sales ratio of Appili Therapeutics Inc (PK)?

The cash to sales ratio of Appili Therapeutics Inc (PK) is 12.83

What is the registered address of Appili Therapeutics Inc (PK)?

The registered address for Appili Therapeutics Inc (PK) is 1344 Summer Street, Halifax, Nova Scotia, B3H 0A8

What is the Appili Therapeutics Inc (PK) website address?

The website address for Appili Therapeutics Inc (PK) is appilitherapeutics.com

Which industry sector does Appili Therapeutics Inc (PK) operate in?

Appili Therapeutics Inc (PK) operates in the Biotechnology & Life Sciences sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Appili Therapeutics Inc (PK) (APLIF)

Appili Therapeutics Inc (PK) (APLIF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Appili Therapeutics Inc (PK) について

APLIF 最新ニュース

Appili Therapeutics to Exhibit at World Vaccine Congress Washington

Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

Appili Therapeutics to Attend BARDA Innovation Symposium 2025

Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

Appili Therapeutics to Present Progress on Tularemia Biodefense Vaccine at NATO CBRN Conference

Appili Therapeutics to Exhibit at World Vaccine Congress Washington

Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement

Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2026

Appili Therapeutics Announces Closing of First Tranche of Non-Brokered Private Placement

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026

Appili Therapeutics Announces Proposed Non-Brokered Private Placement

Appili Therapeutics to Attend BARDA Innovation Symposium 2025

Appili Therapeutics and its Partner Vitalex Biosciences Awarded Contract from NIAID Valued at up to US$40 Million to Develop Fungal Vaccine VXV-01

APLIF - Frequently Asked Questions (FAQ)

APLIF 取引

APLIF Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する